| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 30 | |||
| Accounts receivable | 5 | |||
| Prepaid expenses | 14 | |||
| Total current assets | 49 | |||
| Other assets | 11 | |||
| Total assets | 60 | |||
| Accounts payable and accrued expenses | 99 | |||
| Total current liabilities | 99 | |||
| Note payable, non-current | 150 | |||
| Total liabilities | 249 | |||
| Common stock, 0.001par value, 1,000,000,000 shares authorized, 289,156,340 shares issued and outstanding as of september 30, 2025 and june 30, 2025 | 289 | |||
| Additional paid-in capital | 26,740 | |||
| Accumulated deficit | -27,218 | |||
| Total stockholders' equity (deficit) | -189 | |||
| Total liabilities and stockholders' equity (deficit) | 60 | |||
Cavitation Technologies, Inc. (CVAT)
Cavitation Technologies, Inc. (CVAT)